DURBAN - An infection with the novel coronavirus can lead to coronavirus disease (Covid-19). This can cause mild to severe symptoms. In some people, it leads to life-threatening complications.
Two new Chinese studies, one from researchers at Z
study out of Wuhan University
have outlined a step-by-step path for how the coronavirus goes from mild to deadly:
The virus' spiky proteins latch onto cell receptors found throughout the body called ACE2. It starts by binding to ACE2 receptors in the lungs.
The immune system senses a threat and responds by activating white blood cells. Wuhan researchers found an "obvious increase" in
two types of white blood cells
— leukocytes and neutrophils — and a decrease in lymphocytes (another type of white blood cell) among critically ill patients.
White blood cells release too many cytokines: proteins that further activate the immune response and trigger inflammation in the body.
This "cytokine storm" prompts white blood cells to attack healthy lung tissue. The reaction can lead to severe symptoms including blood clots, excessive leaking in the blood vessels, fluid in the lungs, depleted oxygen in the blood, and low blood pressure.
An aggressive immune response can damage the lungs, heart, kidneys, intestines, and liver. Wuhan researchers found elevated levels of two proteins that may signal a heart attack — highly sensitive troponin I and C-reactive proteins — among severe and critically ill patients.
Proteins and dead cells form a membrane around the alveoli (tiny air sacs in the lungs) making it difficult to absorb oxygen. This can lead to acute respiratory distress syndrome (ARDS), a life-threatening lung injury.
Most coronavirus deaths are due to respiratory failure, but many patients also experience multiple organ failure. Out of 18 patients who died in the study, 17 developed ARDS, 10 suffered from an acute cardiac injury, and 7 suffered from acute kidney injury. All but one patient presented signs of a secondary bacterial infection on the day of death.
For LIVE updates on the Coronavirus pandemic, follow us on Twitter: